Lorimer I - Search Results

1

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy.

Wong B, Bergeron A, Maznyi G, Ng K, Jirovec A, Birdi HK, Serrano D, Spinelli M, Thomson M, Taha Z, Alwithenani A, Chen A, Lorimer I, Vanderhyden B, Arulanandam R, Diallo JS. Wong B, et al. Among authors: lorimer i. Mol Ther. 2023 Nov 1;31(11):3176-3192. doi: 10.1016/j.ymthe.2023.09.017. Epub 2023 Sep 27. Mol Ther. 2023. PMID: 37766429

2

Engineered cells as glioblastoma therapeutics.

Ramanathan A, Lorimer IAJ. Ramanathan A, et al. Among authors: lorimer iaj. Cancer Gene Ther. 2022 Feb;29(2):156-166. doi: 10.1038/s41417-021-00320-w. Epub 2021 Mar 22. Cancer Gene Ther. 2022. PMID: 33753869 Free PMC article. Review.

3

Engineering PTEN-L for Cell-Mediated Delivery.

Lavictoire SJ, Gont A, Julian LM, Stanford WL, Vlasschaert C, Gray DA, Jomaa D, Lorimer IAJ. Lavictoire SJ, et al. Among authors: lorimer iaj. Mol Ther Methods Clin Dev. 2017 Nov 21;9:12-22. doi: 10.1016/j.omtm.2017.11.006. eCollection 2018 Jun 15. Mol Ther Methods Clin Dev. 2017. PMID: 29255742 Free PMC article.

4

Helper-dependent adenoviral vectors containing modified fiber for improved transduction of developing and mature muscle cells.

Bramson JL, Grinshtein N, Meulenbroek RA, Lunde J, Kottachchi D, Lorimer IA, Jasmin BJ, Parks RJ. Bramson JL, et al. Hum Gene Ther. 2004 Feb;15(2):179-88. doi: 10.1089/104303404772679986. Hum Gene Ther. 2004. PMID: 14975190

5

A pharmacodynamic study of the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in metastatic colorectal cancer patients.

Daneshmand M, Parolin DA, Hirte HW, Major P, Goss G, Stewart D, Batist G, Miller WH Jr, Matthews S, Seymour L, Lorimer IA. Daneshmand M, et al. Clin Cancer Res. 2003 Jul;9(7):2457-64. Clin Cancer Res. 2003. PMID: 12855618 Clinical Trial.

6

Coordination of glioblastoma cell motility by PKCι.

Baldwin RM, Barrett GM, Parolin DA, Gillies JK, Paget JA, Lavictoire SJ, Gray DA, Lorimer IA. Baldwin RM, et al. Mol Cancer. 2010 Sep 3;9:233. doi: 10.1186/1476-4598-9-233. Mol Cancer. 2010. PMID: 20815904 Free PMC article.

7

Potential roles for efferocytosis in glioblastoma immune evasion.

Lorimer IAJ. Lorimer IAJ. Neurooncol Adv. 2024 Jan 25;6(1):vdae012. doi: 10.1093/noajnl/vdae012. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38616895 Free PMC article.

8

Antibody recognition of a conformational epitope in a peptide antigen: Fv-peptide complex of an antibody fragment specific for the mutant EGF receptor, EGFRvIII.

Landry RC, Klimowicz AC, Lavictoire SJ, Borisova S, Kottachchi DT, Lorimer IA, Evans SV. Landry RC, et al. Among authors: lorimer ia. J Mol Biol. 2001 May 18;308(5):883-93. doi: 10.1006/jmbi.2001.4628. J Mol Biol. 2001. PMID: 11352579

9

Repression of cancer cell senescence by PKCι.

Paget JA, Restall IJ, Daneshmand M, Mersereau JA, Simard MA, Parolin DA, Lavictoire SJ, Amin MS, Islam S, Lorimer IA. Paget JA, et al. Among authors: lorimer ia. Oncogene. 2012 Aug 2;31(31):3584-96. doi: 10.1038/onc.2011.524. Epub 2011 Nov 28. Oncogene. 2012. PMID: 22120720

10

Induction of premature senescence by hsp90 inhibition in small cell lung cancer.

Restall IJ, Lorimer IA. Restall IJ, et al. PLoS One. 2010 Jun 11;5(6):e11076. doi: 10.1371/journal.pone.0011076. PLoS One. 2010. PMID: 20552022 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page